← Back to Search

Other

Pharmacist-Integrated Care for Opioid Use Disorder (PharmICO Trial)

N/A

Recruiting

Led By Lisa A Marsch, PhD

Research Sponsored by Trustees of Dartmouth College

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months pre-model launch through 12 months post-model launch

Awards & highlights

PharmICO Trial Summary

This trialseeks to find the best way to provide medication treatment for opioid use disorder in 4 sites. Pharmacists will be key partners in this model.

Who is the study for?

This trial is for adults over 18 who work at a clinic as providers, pharmacists, technicians, or administrators. It's also for adult patients at these clinics who are receiving or have received medication treatment for opioid use disorder (MOUD) and have been exposed to the PrIMO model. Participants must not be incarcerated or facing legal issues that prevent study involvement.Check my eligibility

What is being tested?

The trial is testing a new way of treating opioid addiction by integrating pharmacists into the care team. This Phase 1 project will assess how feasible and acceptable it is to implement this pharmacist-integrated model in diverse outpatient clinical settings.See study design

What are the potential side effects?

Since this trial focuses on implementing a service model rather than a specific medical intervention, traditional side effects like those seen with medications are not applicable here.

PharmICO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months pre-model launch through 12 months post-model launch

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months pre-model launch through 12 months post-model launch

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months pre-model launch through 12 months post-model launch for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Stages of Implementation Completion (SIC) Tool

Secondary outcome measures

Applied Mental Health Research Dissemination & Implementation (AMHR) Tool

Beliefs on MOUD Modified

Clinical Sustainability Assessment Tool for PrIMO

+5 more

PharmICO Trial Design

2Treatment groups

Experimental Treatment

Group I: Site StaffExperimental Treatment1 Intervention

Providers, Pharmacists, Pharmacy Technicians, Administrators to receive survey assessments

Group II: PatientsExperimental Treatment1 Intervention

Subset of patients receiving PrIMO care to receive survey assessments

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Trustees of Dartmouth CollegeLead Sponsor

23 Previous Clinical Trials

10,593 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,639 Total Patients Enrolled

Lisa A Marsch, PhDPrincipal InvestigatorGeisel School of Medicine at Dartmouth College

5 Previous Clinical Trials

2,147 Total Patients Enrolled

Media Library

PrIMO (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05310786 — N/A

Substance Use Disorder Research Study Groups: Patients, Site Staff

Substance Use Disorder Clinical Trial 2023: PrIMO Highlights & Side Effects. Trial Name: NCT05310786 — N/A

PrIMO (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05310786 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this medical trial currently available?

"Clinicaltrials.gov reveals that this medical investigation is actively enrolling patients. This trial was unveiled on August 18th 2022 and its requirements were last amended on March 1st 2023."

Answered by AI

How many people have enrolled in this research experiment?

"This experiment requires 92 suitable participants. Those interested can reach out to Community Health Care in Tacoma, Washington or Harbor Health Care in Nashua, New hampshire for more information."

Answered by AI

How many locations are conducting this experiment?

"This clinical trial is recruiting participants at Community Health Care in Tacoma, Washington, Harbor Health Care in Nashua, New hampshire and UNM Truman Health Services in Albuquerque, New mexico among other healthcare facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder

Lisa A. Marsch 2022. "Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05310786.